In fact, CRS has been rarely reported in patients treated only by chemotherapy plus anti-PD-1 antibody.74–76 All these clinical findings collectively supported the notion that Mn2+ addition effectively boosted adaptive immune responses in patients by activating innate immunity. The gene discussed is PDCD1; the disease is congenital rubella syndrome.